WallStreetZenWallStreetZen

NASDAQ: PALI
Palisade Bio Inc Stock Ownership - Who owns Palisade Bio?

Insider buying vs selling

Have Palisade Bio Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Mitchell Lawrence JonesChief Medical Officer2024-02-062,153$0.44
$938.71Sell
John David FinleyCEO CFO Director2024-02-0610,000$0.47
$4.69kBuy
John David FinleyCEO CFO Director2024-01-3110,000$0.56
$5.59kBuy
Donald Allen WilliamsDirector2024-01-3110,000$0.61
$6.05kBuy
John David FinleyCEO CFO Director2023-11-2010,000$0.51
$5.10kBuy
Mitchell Lawrence JonesChief Medical Officer2023-11-071,630$0.54
$878.57Sell
John David FinleyCEO CFO Director2023-10-04397$0.55
$218.35Sell
John David FinleyCEO CFO Director2023-09-2715,000$0.54
$8.09kBuy
Donald Allen WilliamsDirector2023-09-2720,000$0.54
$10.80kBuy
Robert J. TrenschelDirector2023-09-14300$0.64
$192.00Sell

1 of 2

PALI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PALI insiders and whales buy or sell their stock.

PALI Shareholders

What type of owners hold Palisade Bio Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Richard Garr233.30%1,986,304$12.61MInsider
Regional Medical Center Yuma213.10%1,814,375$11.52MInsider
Princeton Capital Corp151.96%1,293,814$8.22MInsider
Stanley Westreich140.15%1,193,281$7.58MInsider
Karl Johe109.28%930,373$5.91MInsider
Robert J. Trenschel37.04%315,399$2.00MInsider
Sandford D. Smith25.83%219,916$1.40MInsider
John Conron13.56%115,492$733.37kInsider
Catherine A. Sohn12.56%106,952$679.15kInsider
John David Finley11.47%97,626$619.93kInsider

1 of 3

PALI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PALI3.08%96.92%Net BuyingNet Buying
SILO5.65%6.35%Net BuyingNet Buying
FRES0.02%38.84%
PXMD1.39%98.61%Net SellingNet Selling
SONN1.86%98.14%Net Buying

Palisade Bio Stock Ownership FAQ

Who owns Palisade Bio?

Palisade Bio (NASDAQ: PALI) is owned by 31.33% institutional shareholders, 984.29% Palisade Bio insiders, and 0.00% retail investors. Richard Garr is the largest individual Palisade Bio shareholder, owning 1.99M shares representing 233.30% of the company. Richard Garr's Palisade Bio shares are currently valued at $12.37M.

If you're new to stock investing, here's how to buy Palisade Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.